Where Will Nautilus Biotechnology Inc (NAUT) Stock Go Next After It Has Risen 5.45% in a Week?

Overall market sentiment has been neutral on Nautilus Biotechnology Inc (NAUT) stock lately. NAUT receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator.

Nautilus Biotechnology Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on NAUT!

See Full NAUT Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With NAUT Stock Today?

Nautilus Biotechnology Inc (NAUT) stock is trading at $3.87 as of 3:00 PM on Friday, Jun 30, a rise of $0.39, or 11.38% from the previous closing price of $3.47. The stock has traded between $3.45 and $3.92 so far today. Volume today is 123,562 compared to average volume of 151,066. To screen for more stocks like Nautilus Biotechnology Inc click here.

More About Nautilus Biotechnology Inc

With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus¿ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine Click Here to get the full Stock Report for Nautilus Biotechnology Inc stock.